Literature DB >> 15650310

Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.

C Rolinck-Werninghaus1, M Kopp, C Liebke, J Lange, U Wahn, B Niggemann.   

Abstract

BACKGROUND: Recent work indicates that subcutaneous specific immunotherapy induces specific T-cell anergy, a shift in the TH1/TH2 ratio, and antibody production in favor of IgG4. There are few data on sublingual immunotherapy (SLIT), especially in children.
METHODS: We assessed the proliferation of peripheral blood mononuclear cells ((3)H-thymidine incorporation) and secretion of interleukin (IL)-4, interferon (IFN)gamma and IL-5 (ELISA) after in vitro stimulation with allergen or phytohemagglutinin (PHA) in 29 children with allergic rhinoconjunctivitis receiving SLIT with grass pollen before, and after 1 and 2 years of treatment in a multicenter placebo-controlled study on the efficacy of the treatment. Further, non-specific intracellular production of IL-4, IL-13, IFNgamma, IL-2, IL-10 and IL-5 (FACS) and serum total and specific IgE and IgG4 (ELISA) were analyzed.
RESULTS: Proliferation and IL-4 and IL-5 secretion after stimulation with allergen or PHA did not differ between the groups. In addition, we observed no effect of SLIT on intracellular cytokine production. IFNgamma secretion after allergen coculture was comparable between the groups. Following PHA stimulation, IFNgamma secretion was significantly higher in the SLIT group after 1 year, and a trend was observable already before and after 2 years of treatment, probably due to the inhomogeneity in the groups despite randomization (for age and asthma). No significant changes were observed for sIgE/sIgG4 ratios over time either in or between the groups.
CONCLUSION: During 2 years of SLIT in children with a positive effect on rescue medication use, we observed no significant effects on in vitro T-cell immune responses or immunoglobulins. So far, pediatric studies demonstrating stable effects of SLIT on such reactions are missing, probably due to limited effects of SLIT on systemic immunologic reactions. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650310     DOI: 10.1159/000083320

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  12 in total

Review 1.  New insights in sublingual immunotherapy.

Authors:  Giovanni Passalacqua; Laura Guerra; Enrico Compalati; Federica Fumagalli; Arianna Cirillo; Giorgio Walter Canonica
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

Review 2.  Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis.

Authors:  Ivana Đurić-Filipović; Marco Caminati; Gordana Kostić; Đorđe Filipović; Zorica Živković
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

3.  Sub-lingual immunotherapy: world allergy organization position paper 2009.

Authors:  G Walter Canonica; Jean Bousquet; Thomas Casale; Richard F Lockey; Carlos E Baena-Cagnani; Ruby Pawankar; Paul C Potter; Philippe J Bousquet; Linda S Cox; Stephen R Durham; Harold S Nelson; Giovanni Passalacqua; Dermot P Ryan; Jan L Brozek; Enrico Compalati; Ronald Dahl; Luis Delgado; Roy Gerth van Wijk; Richard G Gower; Dennis K Ledford; Nelson Rosario Filho; Erkka J Valovirta; Osman M Yusuf; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2009-11-19       Impact factor: 4.084

4.  Effect of sublingual immunotherapy on level of cytokines in PBMCs of patients with allergic asthma.

Authors:  Zhongxi Wang; Wenjing Li; Huan Chen; Wei Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-06-14

Review 5.  Applications and mechanisms of immunotherapy in allergic rhinitis and asthma.

Authors:  Jasper H Kappen; Stephen R Durham; Hans In 't Veen; Mohamed H Shamji
Journal:  Ther Adv Respir Dis       Date:  2016-09-27       Impact factor: 4.031

Review 6.  Allergen immunotherapy for allergic respiratory diseases.

Authors:  Antonio Cappella; Stephen R Durham
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

Review 7.  Subcutaneous and sublingual immunotherapy in children: complete update on controversies, dosing, and efficacy.

Authors:  Désirée Larenas-Linnemann
Journal:  Curr Allergy Asthma Rep       Date:  2008-11       Impact factor: 4.806

Review 8.  Cytokines and other immunological biomarkers in children's environmental health studies.

Authors:  Paurene Duramad; Ira B Tager; Nina T Holland
Journal:  Toxicol Lett       Date:  2007-05-25       Impact factor: 4.372

9.  Sublingual immunotherapy in allergic rhinitis.

Authors:  Doo Hee Han; Chae-Seo Rhee
Journal:  Asia Pac Allergy       Date:  2011-10-11

10.  Sublingual immunotherapy in asthma does not influence lymphocyte sensitivity to Fas stimulation.

Authors:  Olga Ciepiela; A Zawadzka-Krajewska; I Kotula; M Wasik; U Demkow
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.